Insider sale
PASSAGE BIO, INC.
$506.8K
1.46M shares
What this filing means
ORBIMED ADVISORS LLC plans to sell 1.46M shares of PASSAGE BIO, INC. valued at approximately $506.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/24/2025ACC: 0000947871-25-000628
1.46M
Shares to sell
$506.8K
Approx. market value
1.08M
Acquired (3 months)
1
Planned
6 completed
Securities Acquired — Last 3 Months1
IPO
N/A
3/3/2020
1.08MTotal acquired1.08M
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/3/2020 | IPO N/A | 1.08M | — |
| Total | 1.08M | ||
Planned & Completed Dispositions7
Completed
—Completed
Units to sell
68.19K
Market value
$21.8K
4/24/2025
—Completed
Units to sell
89.33K
Market value
$30.4K
4/23/2025
—Completed
Units to sell
78.05K
Market value
$26.5K
4/22/2025
—Completed
Units to sell
77.09K
Market value
$25.4K
4/17/2025
—Completed
Units to sell
61.64K
Market value
$20.3K
4/16/2025
—Completed
Units to sell
10.33K
Market value
$3.9K
4/15/2025
Planned — Approximate Date
Nasdaq Stock MarketPlanned
Units to sell
1.08M
Market value
$378.4K
6/24/2025
Total
Units
1.46M
Value
$506.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/24/2025 | 68.19K | $21.8K | — | Completed |
4/23/2025 | 89.33K | $30.4K | — | Completed |
4/22/2025 | 78.05K | $26.5K | — | Completed |
4/17/2025 | 77.09K | $25.4K | — | Completed |
4/16/2025 | 61.64K | $20.3K | — | Completed |
4/15/2025 | 10.33K | $3.9K | — | Completed |
| Planned — Approximate Date | ||||
6/24/2025 | 1.08M | $378.4K | Nasdaq Stock Market | Planned |
| Total | 1.46M | $506.8K | ||